Legal & General Group
CNST

Legal & General Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Legal & General Group’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,476
Closed -$219K – 3537
2021
Q2 		$219K Sell
6,476
-67
-1% -$1.71K ﹤0.01% 2517
2021
Q1 		$153K Sell
6,543
-300
-4% -$9.09K ﹤0.01% 2505
2020
Q4 		$197K Hold
6,843
– – ﹤0.01% 2424
2020
Q3 		$138K Sell
6,843
-789
-10% -$19.3K ﹤0.01% 2421
2020
Q2 		$229K Buy
7,632
+4,635
+155% +$167K ﹤0.01% 2331
2020
Q1 		$94K Sell
2,997
-132
-4% -$4.59K ﹤0.01% 2434
2019
Q4 		$147K Buy
3,129
+421
+16% +$12.2K ﹤0.01% 2477
2019
Q3 		$17K Hold
2,708
– – ﹤0.01% 3189
2019
Q2 		$27K Hold
2,708
– – ﹤0.01% 3091
2019
Q1 		$37K Buy
2,708
+1,565
+137% +$14K ﹤0.01% 2838
2018
Q4 		$5K Hold
1,143
– – ﹤0.01% 3343
2018
Q3 		$8K Buy
+1,143
New +$10.9K ﹤0.01% 3349

Legal & General Group's CNST Position: Q3 2021 in Review

Legal & General Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 6,476 shares — an estimated $219K sold.

Legal & General Group first reported a position in CNST in Q3 2018 and held it in 12 quarters. The position peaked at $229K in Q2 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Legal & General Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Legal & General Group sold 6,476 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $219K.
  • Legal & General Group first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 12 quarters.
  • Legal & General Group's Constellation Pharmaceuticals, Inc. position peaked at $229K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.